Archives of Gynecology and Obstetrics

, Volume 288, Issue 1, pp 49–55

Plasma lipids and lipoproteins during pregnancy and related pregnancy outcomes

  • Turgay Emet
  • Işık Üstüner
  • Seda Güvendağ Güven
  • Gülşah Balık
  • Ülkü Mete Ural
  • Yeşim Bayoğlu Tekin
  • Şenol Şentürk
  • Figen Kır Şahin
  • Ayşe Filiz Avşar
Maternal-Fetal Medicine

Abstract

Purpose

To study the effect of maternal lipid profile changes in pregnancy in relation to fetal growth and development, prognosis, and complications of pregnancy.

Methods

One thousand pregnant women between 17 and 48 years of age were included in this prospective longitudinal and uni-center study. Lipid profile tests [triglyceride (TG), total cholesterol, high density lipoprotein (HDL), low density lipoprotein (LDL)] were first requested as part of the routine pregnancy follow-up in first antenatal visit (<14 weeks) then repeated in the last trimester (>28 weeks). The analysis included the medical, social-demographic, and nutritional status of the women as well. Primer outcome measures were defined as the association of the pregnancy-related lipid profile change to neonatal weight, the weight of the infant in third month and pregnancy complications (preeclampsia, gestational diabetes mellitus, IUGR, and preterm birth).

Results

The levels of TG, total cholesterol, HDL, LDL increased significantly as pregnancy progressed. The percentage of the change in the TG levels were higher in patients with well nutritional parameters (p = 0.033). As the percentage of change in the TG levels increased, the neonatal weight increased (p = 0.033) but no effect on the placental weight and the third month weight of the infant was seen. As the percent change in TG levels decreased, the risk of the preterm birth significantly increased. In women who were positive in 50 g screening test, but were uncomplicated with gestational diabetes mellitus, the percent change in cholesterol was lower (p = 0.010), the percent change in LDL was lower (p = 0.015), and the percent change in TG was higher (p = 0.032).

Conclusion

In pregnancy, complex alterations occur in lipid metabolism. Percent change in TG is affected positively by the nutrition level. The neonatal weight also increases as well but postnatal weight is unaffected. Conversely TG levels significantly decrease in preterm birth. No association between preeclampsia and gestational diabetes mellitus with lipid profile changes were noted except in patients with glucose intolerance (>140 mg/dl in 50 g screening test) in which change in cholesterol, LDL was low and TG was high.

Keywords

Birth weight Gestational diabetes Hyperlipidemia Lipid metabolism Pregnancy 

References

  1. 1.
    Herrera E, Ortega-Senovilla H (2010) Disturbances in lipid metabolism in diabetic pregnancy—are these the cause of the problem? Best Pract Res Clin Endocrinol Metab 24:515–525PubMedCrossRefGoogle Scholar
  2. 2.
    Murphy SP, Abrams BF (1993) Changes in energy intakes during pregnancy and lactation in a national sample of US women. Am J Public Health 83:1161–1163PubMedCrossRefGoogle Scholar
  3. 3.
    Palacín M, Lasunción MA, Asunción M, Herrera E (1991) Circulating metabolite utilization by periuterine adipose tissue in situ in the pregnant rat. Metabolism 40:534–539PubMedCrossRefGoogle Scholar
  4. 4.
    Ghio A, Bertolotto A, Resi V, Volpe L, Di Cianni G (2011) Triglyceride metabolism in pregnancy. Adv Clin Chem 55:133–153PubMedCrossRefGoogle Scholar
  5. 5.
    Mankuta D, Elami-Suzin M, Elhayani A, Vinker S (2010) Lipid profile in consecutive pregnancies. Lipids Health Dis 9:58PubMedCrossRefGoogle Scholar
  6. 6.
    Herrera E, Lasunción MA, Gomez-Coronado D, Aranda P, López-Luna P, Maier I (1988) Role of lipoprotein lipase activity on lipoprotein metabolism and the fate of circulating triglycerides in pregnancy. Am J Obstet Gynecol 158(6 Pt 2):1575–1583PubMedGoogle Scholar
  7. 7.
    Hytten FE, Leitch I (1971) Component of weight gain. I. The product for conception. In: Hytten FE, Leitch I (eds) Physiology of human pregnancy, 2nd edn. Blackwell Scientific Publications Ltd., Oxford, pp 286–369Google Scholar
  8. 8.
    Butte NF (2000) Carbohydrate and lipid metabolism in pregnancy: normal compared with gestational diabetes mellitus. Am J Clin Nutr 71(5):1256S–1261SPubMedGoogle Scholar
  9. 9.
    Erdogan M, Ustüner I, Cengiz B, Söylemez F, Cavdar AO (2006) Effects of nutrition on zinc, folic acid, and vitamin B12 levels during pregnancy. Biol Trace Elem Res 109:105–113PubMedCrossRefGoogle Scholar
  10. 10.
    Baysal A, Kececioglu S, Guneyli U, Yucecan S, Pekcan G (1988) Food composition table, 2nd edn. Publication of Turkish Dietetic Association, AnkaraGoogle Scholar
  11. 11.
    Institute of Medicine (2001) Food and nutrition board recommended dietary allowances. National Academy Press, WashingtonGoogle Scholar
  12. 12.
    Alvarez JJ, Montelongo A, Iglesias A, Lasunción MA, Herrera E (1996) Longitudinal study on lipoprotein profile, high density lipoprotein subclass, and postheparin lipases during gestation in women. J Lipid Res 37:299–308PubMedGoogle Scholar
  13. 13.
    Salameh WA, Mastrogiannis DS (1994) Maternal hyperlipidemia in pregnancy. Clin Obstet Gynecol 37:66–77PubMedCrossRefGoogle Scholar
  14. 14.
    Desoye G, Schweditsch MO, Pfeiffer KP, Zechner R, Kostner GM (1987) Correlation of hormones with lipid and lipoprotein levels during normal pregnancy and postpartum. J Clin Endocrinol Metab 64:704–712PubMedCrossRefGoogle Scholar
  15. 15.
    Langer O (2000) Fetal macrosomia: etiologic factors. Clin Obstet Gynecol 43:283–297PubMedCrossRefGoogle Scholar
  16. 16.
    Kind KL, Moore VM, Davies MJ (2006) Diet around conception and during pregnancy-effects on fetal and neonatal outcomes. Reprod Biomed Online 12:532–541PubMedCrossRefGoogle Scholar
  17. 17.
    Fowles ER (2004) Prenatal nutrition and birth outcomes. J Obstet Gynecol Neonatal Nurs 33:809–822PubMedCrossRefGoogle Scholar
  18. 18.
    Sermer M, Naylor CD, Gare DJ et al (1995) Impact of increasing carbohydrate intolerance on maternal–fetal outcomes in 3,637 women without gestational diabetes. The Toronto Tri-Hospital Gestational Diabetes Project. Am J Obstet Gynecol 173:146–156PubMedCrossRefGoogle Scholar
  19. 19.
    Ricart W, López J, Mozas J et al (2005) Spanish Group for the Study of the Impact of Carpenter and Coustan GDM Thresholds. Body mass index has a greater impact on pregnancy outcomes than gestational hyperglycemia. Diabetologia 48:1736–1742PubMedCrossRefGoogle Scholar
  20. 20.
    HAPO Study Cooperative Research Group (2010) Hyperglycaemia and Adverse Pregnancy Outcome (HAPO) Study: associations with maternal body mass index. BJOG 117:575–584CrossRefGoogle Scholar
  21. 21.
    Yu CK, Teoh T, Robinson S (2006) Obesity in pregnancy. BJOG 113:1117–1125PubMedCrossRefGoogle Scholar
  22. 22.
    Retnakaran R, Ye C, Hanley AJ, Connelly PW, Sermer M, Zinman B, Hamilton JK (2012) Effect of maternal weight, adipokines, glucose intolerance and lipids on infant birth weight among women without gestational diabetes mellitus. CMAJ 184:1353–1360PubMedGoogle Scholar
  23. 23.
    Knopp RH, Magee MS, Walden CE, Bonet B, Benedetti TJ (1992) Prediction of infant birth weight by GDM screening tests. Importance of plasma triglyceride. Diabetes Care 15:1605–1613PubMedCrossRefGoogle Scholar
  24. 24.
    Metzger BE, Lowe LP, Dyer AR et al (2008) HAPO Study Cooperative Research Group. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med 358:1991–2002PubMedCrossRefGoogle Scholar
  25. 25.
    Di Cianni G, Miccoli R, Volpe L et al (2005) Maternal triglyceride levels and newborn weight in pregnant women with normal glucose tolerance. Diabet Med 22:21–25PubMedCrossRefGoogle Scholar
  26. 26.
    Kitajima M, Oka S, Yasuhi I, Fukuda M, Rii Y, Ishimaru T (2001) Maternal serum triglyceride at 24–32 weeks gestation and newborn weight in nondiabetic women with positive diabetic screens. Obstet Gynecol 97(5 Pt 1):776–780PubMedCrossRefGoogle Scholar
  27. 27.
    Merzouk H, Meghelli-Bouchenak M, el-Korso N, Belleville J, Prost J (1998) Low birth weight at term impairs cord serum lipoprotein compositions and concentrations. Eur J Pediatr 157:321–326PubMedCrossRefGoogle Scholar
  28. 28.
    Smith GC, Pell JP, Walsh D (2001) Pregnancy complications and maternal risk of ischaemic heart disease: a retrospective cohort study of 129,290 births. Lancet 357:2002–2006PubMedCrossRefGoogle Scholar
  29. 29.
    Catov JM, Bodnar LM, Kip KE, Hubel C, Ness RB, Harger G, Roberts JM (2007) Early pregnancy lipid concentrations and spontaneous preterm birth. Am J Obstet Gynecol 197:610.e1–617.e1CrossRefGoogle Scholar
  30. 30.
    Catov JM, Bodnar LM, Ness RB, Barron SJ, Roberts JM (2007) Inflammation and dyslipidemia related to risk of spontaneous preterm birth. Am J Epidemiol 166:1312–1319PubMedCrossRefGoogle Scholar
  31. 31.
    Chatzi L, Plana E, Daraki V, Karakosta P, Alegkakis D, Tsatsanis C, Kafatos A, Koutis A, Kogevinas M (2009) Metabolic syndrome in early pregnancy and risk of preterm birth. Am J Epidemiol 170:829–836PubMedCrossRefGoogle Scholar
  32. 32.
    Khovidhunkit W, Kim MS, Memon RA, Shigenaga JK, Moser AH, Feingold KR, Grunfeld C (2004) Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. J Lipid Res 45:1169–1196PubMedCrossRefGoogle Scholar
  33. 33.
    Potter JM, Nestel PJ (1979) The hyperlipidemia of pregnancy in normal and complicated pregnancies. Am J Obstet Gynecol 133:165–170PubMedGoogle Scholar
  34. 34.
    Ray JG, Diamond P, Singh G, Bell CM (2006) Brief overview of maternal triglycerides as a risk factor for pre-eclampsia. BJOG 113:379–386PubMedCrossRefGoogle Scholar
  35. 35.
    Lorentzen B, Endresen M, Clausen T, Henriksen T (1994) Fasting serum free fatty acids and triglycerides are increased before 20 weeks of gestation in women who later develop preeclampsia. Hypertens Pregnancy 13:103–109CrossRefGoogle Scholar
  36. 36.
    Baker AM, Klein RL, Moss KL, Haeri S, Boggess K (2009) Maternal serum dyslipidemia occurs early in pregnancy in women with mild but not severe preeclampsia. Am J Obstet Gynecol 201:293.e1–294.e1CrossRefGoogle Scholar
  37. 37.
    Wiznitzer A, Mayer A, Novack V, Sheiner E, Gilutz H, Malhotra A, Novack L (2009) Association of lipid levels during gestation with preeclampsia and gestational diabetes mellitus: a population-based study. Am J Obstet Gynecol 201:482.e1–488.e1CrossRefGoogle Scholar
  38. 38.
    Vrijkotte TG, Krukziener N, Hutten BA, Vollebregt KC, van Eijsden M, Twickler MB (2012) Maternal lipid profile during early pregnancy and pregnancy complications and outcomes: the ABCD study. J Clin Endocrinol Metab 97:3917–3925PubMedCrossRefGoogle Scholar
  39. 39.
    Sánchez-Vera I, Bonet B, Viana M, Quintanar A, Martín MD, Blanco P, Donnay S, Albi M (2007) Changes in plasma lipids and increased low-density lipoprotein susceptibility to oxidation in pregnancies complicated by gestational diabetes: consequences of obesity. Metabolism 56:1527–1533PubMedCrossRefGoogle Scholar
  40. 40.
    Hollingsworth DR, Grundy SM (1982) Pregnancy-associated hypertriglyceridemia in normal and diabetic women. Differences in insulin-dependent, non-insulin-dependent, and gestational diabetes. Diabetes 31:1092–1097PubMedGoogle Scholar
  41. 41.
    Koukkou E, Watts GF, Lowy C (1996) Serum lipid, lipoprotein and apolipoprotein changes in gestational diabetes mellitus: a cross-sectional and prospective study. J Clin Pathol 49:634–637PubMedCrossRefGoogle Scholar
  42. 42.
    Montelongo A, Lasunción MA, Pallardo LF, Herrera E (1992) Longitudinal study of plasma lipoproteins and hormones during pregnancy in normal and diabetic women. Diabetes 41:1651–1659PubMedCrossRefGoogle Scholar
  43. 43.
    Marseille-Tremblay C, Ethier-Chiasson M, Forest JC, Giguère Y, Masse A, Mounier C, Lafond J (2008) Impact of maternal circulating cholesterol and gestational diabetes mellitus on lipid metabolism in human term placenta. Mol Reprod Dev 75:1054–1062PubMedCrossRefGoogle Scholar
  44. 44.
    Rizzo M, Berneis K, Altinova AE, Toruner FB, Akturk M, Ayvaz G, Rini GB, Spinas GA, Arslan M (2008) Atherogenic lipoprotein phenotype and LDL size and subclasses in women with gestational diabetes. Diabet Med 25:1406–1411PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  • Turgay Emet
    • 1
  • Işık Üstüner
    • 1
  • Seda Güvendağ Güven
    • 1
  • Gülşah Balık
    • 1
  • Ülkü Mete Ural
    • 1
  • Yeşim Bayoğlu Tekin
    • 1
  • Şenol Şentürk
    • 1
  • Figen Kır Şahin
    • 1
  • Ayşe Filiz Avşar
    • 2
  1. 1.Department of Obstetrics and GynecologyRecep Tayyip Erdoğan University School of MedicineRizeTurkey
  2. 2.Department of Obstetrics and GynecologyYıldırım Beyazıt University School of MedicineAnkaraTurkey

Personalised recommendations